-
With only half a brain left, the accuracy of people reading and seeing faces can reach 80% PNAS
Time of Update: 2022-11-15
Alex from the Recessed Temple Qubit | Official number QbitAIOnly half of the brain remains, and people can still think, and it is still a relatively normal kind! (Don't be afraid, this article is not
-
Zeng Yi's team of the Chinese Academy of Sciences empowers the self-organized obstacle avoidance ability of UAV clusters based on the pulsed neural network of reward regulation Cell Press paper express
Time of Update: 2022-11-15
InterdisciplinaryInterdisciplinaryOn October 28, 2022, the research group of researcher Zeng Yi of the Institute of Automation of the Chinese Academy of Sciences published an article entitled "Nature-inspired self-organizing collision avoidance for drone swarm based on reward-modulated spiking neural" in the Cell Press journal Patterns Network".
-
Value of TK supplementation therapy in the treatment of acute ischemic stroke The 3rd Annual Conference of Shanghai Stroke Society and the 16th China Neurology Forum
Time of Update: 2022-11-15
The consistent evidence from domestic and foreign studies will provide more evidence for stroke treatmentAt the end of the meeting, Professor Wang Xin concluded that at present, many Chinese groups of studies have been carried out in China on the relationship between TK and AIS, and the effect of TK complementary therapy and AIS therapy, which suggest that TK plays an increasingly important role in clinical practice.
-
After years of research, is Alzheimer's disease an autoimmune disease?
Time of Update: 2022-11-15
*For medical professionals onlyAt the end of the article, there is a wonderful comment from Professor Han Ying of Xuanwu Hospital of Capital Medical University, which should not be missedOn September
-
ECTRIMS 2022 focuses on the latest research advances in Sinimod
Time of Update: 2022-11-15
Disability progression remained stable and satisfaction was high in patients with active SPMS after 12 months of treatment with siponimod – AMASIA real-world studyThe AMASIA study is a long-term, non-interventionive, real-world study conducted in Germany that for the first time analyzed the long-term efficacy and safety of siponimod and its impact on quality of life and socioeconomic status.
-
How to use dobazazine tablets for Parkinson's disease? These 6 points to know!
Time of Update: 2022-11-15
In patients in the honeymoon phase of the drug, small doses of dopaserazide tablets taken orally 2-3 times a day may control symptoms very stably.
In patients in the honeymoon phase of the drug, small doses of dopaserazide tablets taken orally 2-3 times a day may control symptoms very stably.
-
Forgotten for decades, these molecules may be used to combat brain aging
Time of Update: 2022-11-15
▲ With age, SGDG molecules in the brain gradually decrease (Image source: Reference [1])Data analysis showed that lipid levels in the brains of old mice differed greatly from those of young mice, with SGDG and its associated members, such as potential degradation products, decreasing significantly with age, suggesting that they may play a role in brain aging.
-
Understanding the Autistic Brain is the most comprehensive molecular study published today in Nature to date
Time of Update: 2022-11-15
Retrieved Nov. 3, 2022 from style="outline: 0px;visibility: visible;">▎WuXi AppTec content team editor Autism, also known as autism spectrum disorder (ASD) in medicine, is a complex brain disorder that has gradually attracted public attention in recent years.
-
Express significantly improves the symptoms of drowsiness, and innovative therapies show positive clinical results
Time of Update: 2022-11-15
Image source: 123RFThe Phase 2 clinical trial is a randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of pitolisant in PWS patients with primary endpoints of change in ESS-CHAD parent/caregiver version scores from baseline to end of treatment (EOT).
-
Cell sub-journal: Ming Guoli/Song Hongjun's team established a transcriptomic reference map of glial cells in the human hippocampus
Time of Update: 2022-11-15
On November 3, 2022, the team of Professor Guoli Ming and Professor Hongjun Song of the University of Pennsylvania published a publication in the journal Cell Stem Cell: A single-cell transcriptome at
-
Express Advance the development of treatments for refractory depression, and Cutting-edge completed a $60 million Series A financing
Time of Update: 2022-11-15
▲If you have any business needs, please long press to scan the QR code above, or▎WuXi AppTec content team editorLusaris Therapeutics announced the completion of a $60 million Series A funding round to advance the development of therapies for severe neuropsychiatric disorders and neurological disorders.
-
JAMA subjournal: Large-scale infarction in the extended time window after stroke greatly benefits from vascular recanalization within 17.6 hours
Time of Update: 2022-11-15
▎WuXi AppTec content team editorThe New England Journal of Medicine (NEJM) has published the results of the landmark DAWN trial and DEFUSE-3 trial, confirming that patients with large-vessel occlusive
-
SCI ADV-Tai Yanlong's research group proposed an artificial remote sensing haptic device with three-dimensional depth perception
Time of Update: 2022-11-15
In this work, the research team proposed a stretchable self-powered three-dimensional remote tactile device (3D-RTD) that passes through a novel heterostructure Realize the perception of the mechanical movement of external objects in the depth-of-field (DOF) direction.
-
Picking your nose is cool for a while, digging the crematorium all the time! Latest Research: "Picking Your Nose" Increases Your Risk of Alzheimer's Disease!
Time of Update: 2022-11-15
Researchers from New York University's Grossman School of Medicine found that frequent nose picking may cause Chlamydia pneumoniae to mediate the nerves between the nasal cavity and the brain as an invasion pathway, invade the central nervous system, and induce the deposition of amyloid β brain cells, thereby increasing the risk of Alzheimer's disease and dementia!
-
Neurology: Scientists have found that obese women have a significantly lower risk of Parkinson's disease!
Time of Update: 2022-11-15
This study uses long-term follow-up cohort and a variety of repeated measured weight indexes to overcome the shortcomings in previous studies and confirm the interesting inverse association between body mass index and Parkinson's disease risk, which provides ideas and references for future research design and development.
-
Nature: Prevent addiction and protect the liver! The Peking University team revealed that gut microbes degrade nicotine to improve non-alcoholic fatty liver disease
Time of Update: 2022-11-15
1Intestinal xylolytic bacteroides degrade nicotine in the ileumThe research team collected ileal mucosa, serum and resolution samples from 30 non-smokers and smokers for mass spectrometry analysis, and found that the nicotine content of the ileal mucosa of the smokers increased significantly, indicating that nicotine was enriched in the ileum.
-
The Mol Neurobiol—Xu Kaibiao/Gao Yibo team discovered the underlying pathological mechanisms of new-onset refractory status epilepticus caused by different causes
Time of Update: 2022-11-15
Written by He Fenfen, Wang Dongmei, Xu Kaibiao - Wang Sizhen, Fang Yiyi - Xia Ye New-onset refractory status epilepticus (NORSE) is a rare neurological disease with a high disability and mortality rat
-
ESO released the guidelines for long-term secondary prevention after ischemic stroke or transient ischemic attack, and the latest recommendations are expressed!
Time of Update: 2022-11-15
Expert consensus statement:For patients with a history of prior ischaemic stroke or TIA for more than 1 month, antiplatelet therapy combined with low-dose direct-to-mouth oral anticoagulant (rivaroxaban) may be considered to optimize the treatment of coronary artery disease or peripheral artery disease.
-
Li Lei's team at ShanghaiTech University found that ALS mutant genes regulate DNA damage repair
Time of Update: 2022-11-15
6s ease 0s;letter-spacing: normal;font-size: 12px;" _mstmutation="1" _istranslated="1"> Open reprint welcome to forward to Moments and WeChat groups Amyotrophic lateral sclerosis, also known as ALS)is a rapidly progressive neurodegenerative disease that affects up and down motor neurons.
-
Neuron Huang's team found that a new blood-tumor barrier composed of mechanically sensitive tumor cells hindered brain tumor chemotherapy
Time of Update: 2022-11-15
++Knocking out Piezo2 reversed the WNT/β-Catenin signaling state between Sox2+ tumor cells and vascular endothelial cells, and activated resting Sox2+ tumor cells while destroying the blood-tumor barrier, greatly enhancing the response of medulloblastoma to chemotherapy.
